Stimulating your mind, upgrading your body, and elevating your soul daily.
Engineered T-cells from a donor point the way to cancer cure in 2 infants suffering from leukemia. This post from MIT Technology Review highlights the incredible medical feat. Doctors in London say they have cured two babies of leukemia in the world’s first attempt to treat cancer with genetically engineered immune cells from a donor. The experiments, which took place at ... Continue Reading
The first human trials of gene-editing technology CRISPR have just been approved. This post from Futurism sheds light on what RAC’s nod for the first human use of CRISPR entails.APPROVED!A proposal from doctors at the University of Pennsylvania for the first human use of CRISPR technology to treat cancer has just passed its first regulatory hurdle, getting the go-ahead from the ... Continue Reading
It's really happening. Scientists have found a way to a 'universal cancer vaccine' that persuades the body's immune system to attack tumors. Human trials begin. This post from ScienceAlert turns the spotlight on the early research that has demonstrated the results in mice.Scientists just took a big, "very positive" step towards developing what could be the first 'universal ... Continue Reading
Researchers have discovered a new way to sharpen the precision of cancer immunotherapy based on the complexity of cancer cells and their antigens. This post from Fortune sheds light on a major breakthrough that scientists have made in personalized cancer treatment. It could herald a new era in precision therapies for cancers. Scientists at the University College London (UCL) ... Continue Reading
A new type of immunotherapy using engineered immune cells to kill cancer has given astounding results in blood cancer trial. This post from KurzweilAI sheds light on the immunotherapy treatment trial that has resulted in dramatic remissions in blood cancer. Recent advances in an immune-cell cancer treatment — a type of immunotherapy* using engineered immune cells to target ... Continue Reading
Send this to friend
